Related Experiment Video
Updated: May 15, 2026

Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
Cow's milk allergy, asthma, and pediatric IBD
Lauri J Virta1, Merja Ashorn, Kaija-Leena Kolho
1Department of Research, Social Insurance Institution, Turku, Finland.
Insights
Cow's milk allergy in infancy is a risk factor for pediatric inflammatory bowel disease (IBD). Childhood asthma is also linked to an increased risk of Crohn's disease, a type of IBD.
Area of Science:
- Pediatric Gastroenterology
- Immunology
- Epidemiology
Background:
- Inflammatory bowel disease (IBD) encompasses Crohn's disease and ulcerative colitis, affecting children and adults.
- The etiology of pediatric IBD is multifactorial, involving genetic and environmental factors.
- Cow's milk allergy (CMA) and asthma are common childhood conditions with potential immune system involvement.
Purpose of the Study:
- To investigate the association between early-life cow's milk allergy (CMA) and childhood asthma with the subsequent risk of developing pediatric inflammatory bowel disease (IBD).
- To determine if CMA or asthma are independent risk factors for IBD subtypes, Crohn's disease (CD) and ulcerative colitis (UC).
Main Methods:
- A population-based cohort study utilizing the Finnish National Reimbursement Register.
- Identified 595 children diagnosed with IBD between 1994-2008.
- Matched each IBD case with 2380 controls to assess the odds ratios for CMA and asthma diagnoses.
Main Results:
- Infancy diagnosis of CMA was significantly associated with an increased risk of both Crohn's disease (OR 1.92) and ulcerative colitis (OR 1.71).
- Childhood asthma diagnosis was significantly associated with an increased risk of Crohn's disease (OR 2.33).
- These associations remained statistically significant after controlling for potential confounders.
Conclusions:
- Cow's milk allergy in infancy represents a significant risk factor for the development of pediatric inflammatory bowel disease.
- Childhood asthma is identified as a specific risk factor for Crohn's disease.
- Findings suggest a potential role for immune dysregulation in the pathogenesis of pediatric IBD.
Abstract:
We identified a total of 595 Finnish children born in 1994-2008 and diagnosed as having inflammatory bowel disease (IBD) by October 2010 from the National Reimbursement Register (based on certificates including the diagnostic criteria) to determine whether the presence of cow's milk allergy (CMA) or asthma is associated with the risk of contracting IBD (altogether 2380 matched controls). A diagnosis of CMA in infancy was associated with Crohn disease (odds ratio [OR] 1.92, confidence interval [CI] 1.09-3.36, P < 0.05) and ulcerative colitis (OR 1.71, CI 1.04-2.83, P < 0.05), but childhood asthma only with Crohn disease (OR 2.33, CI 1.41-3.86, P = 0.001). Thus, CMA in infants is a risk factor for contracting pediatric IBD and accordingly, asthma for Crohn disease.
Related Concept Videos
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma I: Introduction
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Asthma-I: Introduction
Allergic Reactions: Anaphylaxis

